Summary of the ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
D005572:Formularies, Hospital as Topic; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D012957:Societies, Pharmaceutical; D014481:United States
D016756:Immunoglobulins, Intravenous